恶性肿瘤分子靶治疗.pptVIP

  • 4
  • 0
  • 约5.66万字
  • 约 69页
  • 2018-11-30 发布于江苏
  • 举报
恶性肿瘤分子靶治疗

Comments. When we take of look of the survival figures between clinical trials, you can see for surgery alone, the 5 yrs survival rate is ~10% (which is signifying cure in ca pancreas). but in the presence of adjuvant chemo, the 5 yr survival rate has improved to 20% in chemo arm in ESPAC-1 and CONKO-01, In current ESPAC-3 study, the results further consolidate the benefits of adjuvant chemotherapy with very similar figure to the chemo arm of previous trials, meaning that the adjuvant chemotherapy could help cure some of the patients. Remember that the 5yr survival rate means cure in patients

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档